In a joint paper and press release, major trade associations for cell and gene therapy developers are calling for relaxation of EU regulations that treat these advanced therapies as genetically ...
Few topics are as divisive and controversial as genetically modified organisms (GMOs). The same level of contention also characterises new genomic techniques (NGTS), often referred to as the new ...